A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

The discussion shed light on the complex relationships people have with food and the urgent need for robust action to address ...

In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales ...

Donald Trump is a huge fan - but a raft of studies suggest we may not completely escape the negative effects of fizzy drinks ...

Leading health experts challenge traditional BMI measurements and introduce a comprehensive new approach to diagnosing obesity, potentially affecting millions.

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Experts said "unhealthy habits" and "risk taking behaviour" could be a partial cause, with more supported needed for those ...

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.